Predictive Markers of Response and Toxicity in Patients With a Haematological Malignancy Treated With Immunotherapy.
NCT05450367
·
clinicaltrials.gov ↗
COMPLETED
Status
249
Enrollment
OTHER
Sponsor class
Conditions
Blood Cancer
Interventions
OTHER:
Data collection
Sponsor
Assistance Publique - Hôpitaux de Paris
Collaborators
[object Object]